Rockwell Medical (RMTI) Asset Writedowns and Impairment (2025)

Rockwell Medical (RMTI) reported Asset Writedowns and Impairment of $22000.0 for Q4 2025, down 87.64% quarter-over-quarter from $178000.0 in Q1 2025.

Rockwell Medical (RMTI) Asset Writedowns and Impairment (2025) Analysis & Trends

Rockwell Medical has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $22000.0 in Q4 2025.

For the quarter ending Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $22000.0; the trailing twelve-month figure through Mar 2026 stood at $22000.0 (down 87.64% YoY), and the FY2025 full-year result was $200000.0, changed N/A from the prior year.
Asset Writedowns and Impairment for Q4 2025 stood at $22000.0, down from $178000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $178000.0 in Q1 2025, with the low at $22000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.77 Bn	35.04 Bn	1.97 Bn
2	Zoetis	34.11 Bn	32.16 Bn	1.62 Bn
3	United Therapeutics	23.68 Bn	21.53 Bn	648.10 Mn
4	Aurora Cannabis	16.48 Bn	16.40 Bn	33.43 Mn
5	Neurocrine Biosciences	16.19 Bn	14.88 Bn	800.70 Mn
6	Elanco Animal Health	11.44 Bn	11.01 Bn	785.00 Mn
7	Alkermes	7.28 Bn	6.77 Bn	-116.06 Mn
8	Lantheus Holdings	6.48 Bn	5.98 Bn	230.92 Mn
9	Hims & Hers Health	6.35 Bn	5.60 Bn	396.79 Mn
10	Rockwell Medical	26.31 Mn	2.42 Mn	2.90 Mn

Download Data